Single and Multivariate Associations of MSR1, ELAC2, and RNASEL with Prostate Cancer in an Ethnic Diverse Cohort of Men
Authors:
- 1 February 2010
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 19 (2) , 588-599
Abstract
Three genes, namely, ELAC2 (HPC2 locus) on chromosome 17p11, 2′-5′-oligoisoadenlyate-synthetase-dependent ribonuclease L (RNASEL, HPC1 locus), and macrophage scavenger receptor 1 (MSR1) within a region of linkage on chromosome 8p, have been identified as hereditary tumor suppressor genes in prostate cancer. We genotyped 41 tagged single nucleotide polymorphisms (SNPs) covering the three genes in a case-control cohort, which included 1,436 Caucasians, 648 Hispanics, and 270 African Americans. SNPs within MSR1, ELAC2, and RNASEL were significantly associated with risk of prostate cancer albeit with differences among the three ethnic groups (P = 0.043-1.0 × 10−5). In Caucasians, variants within MSR1 and ELAC2 are most likely to confer prostate cancer risk, and rs11545302 (ELAC2) showed a main effect independent of other significant SNPs (P = 2.03 × 10−5). A major haplotype G-A-C-G-C-G combining five SNPs within MSR1 was further shown to increase prostate cancer risk significantly in this study group. Variants in RNASEL had the strongest effects on prostate cancer risk estimates in Hispanics and also showed an interaction effect of family history. In African Americans, single SNPs within MSR1 were significantly associated with prostate cancer risk. A major risk haplotype C-G-G-C-G of five SNPs within ELAC2 was found in this group. Combining high-risk genotypes of MSR1 and ELAC2 in Caucasians and of RNASEL and MSR1 in Hispanics showed synergistic effects and suggest that an interaction between both genes in each ethnicity is likely to confer prostate cancer risk. Our findings corroborate the involvement of ELAC2, MSR1, and RNASEL in the etiology of prostate cancer even in individuals without a family history. Cancer Epidemiol Biomarkers Prev; 19(2); 588–99Keywords
This publication has 53 references indexed in Scilit:
- Concordance of Survival in Family Members With Prostate CancerJournal of Clinical Oncology, 2008
- Sequence variants of elaC homolog 2 (Escherichia coli) ( ELAC2 ) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up StudyCarcinogenesis, 2008
- Viral Encounters with 2′,5′-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral ResponseJournal of Virology, 2007
- DNA copy number alterations in prostate cancers: A combined analysis of published CGH studiesThe Prostate, 2007
- An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumorsProceedings of the National Academy of Sciences, 2007
- A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart StudyBMC Medical Genetics, 2007
- Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL VariantPLOS Pathogens, 2006
- Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 2004
- Statistical significance for genomewide studiesProceedings of the National Academy of Sciences of the United States of America, 2003
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002